These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17331982)

  • 21. NMDA receptor antagonists for the treatment of neuropathic pain.
    Collins S; Sigtermans MJ; Dahan A; Zuurmond WW; Perez RS
    Pain Med; 2010 Nov; 11(11):1726-42. PubMed ID: 21044263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eliciting paresthesias for peripheral nerve block: a harmful clinical standard?
    Kiefer RT
    Anesth Analg; 2001 Mar; 92(3):795-6. PubMed ID: 11226122
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the pharmacological properties of GK11 and MK801, two NMDA receptor antagonists: towards an explanation for the lack of intrinsic neurotoxicity of GK11.
    Vandame D; Desmadryl G; Becerril Ortega J; Teigell M; Crouzin N; Buisson A; Privat A; Hirbec H
    J Neurochem; 2007 Nov; 103(4):1682-96. PubMed ID: 17908242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMDA receptors, glial cells, and clinical medicine.
    Lipton SA
    Neuron; 2006 Apr; 50(1):9-11. PubMed ID: 16600850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of the NMDA receptor antagonist MK-801 on the acquisition and extinction of learned fear in the developing rat.
    Langton JM; Kim JH; Nicholas J; Richardson R
    Learn Mem; 2007 Oct; 14(10):665-8. PubMed ID: 17909101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologically activated therapeutics for neuroprotection.
    Lipton SA
    Nat Rev Neurosci; 2007 Oct; 8(10):803-8. PubMed ID: 17882256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition.
    Jung KH; Chu K; Lee ST; Park HK; Kim JH; Kang KM; Kim M; Lee SK; Roh JK
    Biochem Biophys Res Commun; 2009 Jan; 378(3):507-12. PubMed ID: 19056343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memantine as a neuroprotective agent in early phases of psychosis.
    Fusar-Poli P; Pellegrini F; Cortesi M
    Med Hypotheses; 2007; 68(2):459-60. PubMed ID: 17005328
    [No Abstract]   [Full Text] [Related]  

  • 29. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.
    Bubeníková-Valesová V; Horácek J; Vrajová M; Höschl C
    Neurosci Biobehav Rev; 2008 Jul; 32(5):1014-23. PubMed ID: 18471877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ketamine, dextromethorphan, and MK-801 on cochlear dysfunction induced by transient ischemia.
    Tabuchi K; Tsuji S; Wada T; Ito Z; Hara A; Kusakari J
    Ann Otol Rhinol Laryngol; 2002 Jan; 111(1):44-9. PubMed ID: 11800369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of NMDA antagonist in perioperative pain management.
    Chan KH
    Acta Anaesthesiol Sin; 1999 Dec; 37(4):171-2. PubMed ID: 10670113
    [No Abstract]   [Full Text] [Related]  

  • 32. NMDA receptors and behavioural sensitization: beyond dizocilpine.
    Wolf ME
    Trends Pharmacol Sci; 1999 May; 20(5):188-9; author reply 189-90. PubMed ID: 10354611
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of NMDA-receptor antagonists in the treatment of chronic pain.
    Hewitt DJ
    Clin J Pain; 2000 Jun; 16(2 Suppl):S73-9. PubMed ID: 10870744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
    Koutsilieri E; Riederer P
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S329-31. PubMed ID: 18267259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain.
    Siu A; Drachtman R
    CNS Drug Rev; 2007; 13(1):96-106. PubMed ID: 17461892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-methyl-D-aspartate receptor antagonists for migraine: a potential therapeutic approach.
    Ye R; Kong X; Han J; Zhao G
    Med Hypotheses; 2009 May; 72(5):603-5. PubMed ID: 19168292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-methyl-D-aspartate (NMDA) antagonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries.
    Kamel IR; Wendling WW; Chen D; Wendling KS; Harakal C; Carlsson C
    J Neurosurg Anesthesiol; 2008 Oct; 20(4):241-8. PubMed ID: 18812887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that Xenon does not produce open channel blockade of the NMDA receptor.
    Weigt HU; Adolph O; Georgieff M; Georgieff EM; Föhr KJ
    J Neurophysiol; 2008 Apr; 99(4):1983-7. PubMed ID: 18234987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of dextromethorphan administration in 18 patients with subacute methotrexate central nervous system toxicity.
    Afshar M; Birnbaum D; Golden C
    Pediatr Neurol; 2014 Jun; 50(6):625-9. PubMed ID: 24742799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis.
    Wallström E; Diener P; Ljungdahl A; Khademi M; Nilsson CG; Olsson T
    J Neurol Sci; 1996 May; 137(2):89-96. PubMed ID: 8782160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.